Analysts think CSBR stock price could increase by 25%
Jul 31, 2024, 6:26 AM
-13.03%
What does CSBR do
Champions Oncology, Inc., based in Baltimore, Maryland, develops and sells personalized oncology drug development technologies, employing 230 people and operating a research center in both regulatory and non-regulatory environments. The company offers TumorGraft Technology Platform services to biopharma firms and runs a software-as-a-service business through its Lumin Bioinformatics platform, which integrates data from research and clinical studies for drug discovery and development.
3 analysts think CSBR stock price will increase by 24.64%. The current median analyst target is $6.12 compared to a current stock price of $4.91. The lowest analysts target is $6.06 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.